Forte Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 1.64 M | $24.54 M | 1.07% | 13.93% |
| FEDERATED HERMES, INC. | 11/03/2025 | 1.64 M | $24.53 M | 52.52% | 13.93% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.40 M | $20.98 M | 0.64% | 11.95% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.20 M | $17.95 M | 0.00% | 10.19% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 11/06/2025 | 786.65 K | $11.80 M | 0.00% | 6.70% |
| VANGUARD GROUP INC | 11/07/2025 | 566.74 K | $8.50 M | 16.39% | 4.83% |
| CABLE CAR CAPITAL LLC | 11/14/2025 | 500.00 K | $7.50 M | 0.00% | 4.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 474.31 K | $7.11 M | -4.20% | 4.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 333.33 K | $5.00 M | 0.00% | 2.84% |
| WOODLINE PARTNERS LP | 11/14/2025 | 331.99 K | $4.98 M | 0.00% | 2.83% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 300.00 K | $4.50 M | -37.03% | 2.55% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2025 | 261.82 K | $3.93 M | 100.00% | 2.23% |
| FMR LLC | 11/13/2025 | 244.40 K | $3.67 M | 100.00% | 2.08% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 119.81 K | $1.80 M | 66.14% | 1.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 108.32 K | $1.63 M | 68.96% | 0.92% |
| MINK BROOK ASSET MANAGEMENT LLC | 11/14/2025 | 81.31 K | $1.22 M | 109.07% | 0.69% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 69.89 K | $1.05 M | 100.00% | 0.60% |
| BVF INC/IL | 11/14/2025 | 65.35 K | $980.25 K | -88.89% | 0.56% |
| BLACKROCK, INC. | 11/12/2025 | 50.66 K | $759.93 K | 50.35% | 0.43% |
| STATE STREET CORP | 11/14/2025 | 38.10 K | $571.46 K | 100.00% | 0.32% |
| ENVESTNET ASSET MANAGEMENT INC | 11/05/2025 | 23.35 K | $350.21 K | 23.82% | 0.20% |
| NORTHERN TRUST CORP | 11/14/2025 | 23.29 K | $349.28 K | 100.00% | 0.20% |
| MARSHALL WACE, LLP | 11/13/2025 | 19.17 K | $287.48 K | 100.00% | 0.16% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 16.20 K | $243.00 K | 100.00% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2025 | 15.63 K | $234.50 K | 100.00% | 0.13% |
| QUEST PARTNERS LLC | 11/03/2025 | 12.29 K | $184.37 K | -27.26% | 0.10% |
| ROYAL BANK OF CANADA | 11/14/2025 | 11.25 K | $169.00 K | 21.86% | 0.10% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 10.77 K | $161.01 K | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.16 K | $47.37 K | 5,641.82% | 0.03% |
| UBS GROUP AG | 11/13/2025 | 1.56 K | $23.40 K | 155,900.00% | 0.01% |
| BARCLAYS PLC | 11/12/2025 | 820 | $12.30 K | 100.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 553 | $8.30 K | 100.00% | 0.00% |
| PRIVATE TRUST CO NA | 10/15/2025 | 274 | $4.11 K | 42.71% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 162 | $2.43 K | 100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 151 | $2.27 K | 0.00% | 0.00% |
| COMERICA BANK | 11/14/2025 | 150 | $2.25 K | -4.46% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 104 | $1.56 K | 0.00% | 0.00% |
| ASSETMARK, INC | 11/06/2025 | 81 | $1.22 K | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 13 | $195 | 8.33% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 8 | $120 | 0.00% | 0.00% |
| REAP FINANCIAL GROUP, LLC | 11/06/2025 | 3 | $45 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 2 | $30 | 0.00% | 0.00% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 11/18/2025 | 0 | $0 | -100.00% | 0.00% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Forte Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 51 institutional investors and hedge funds held shares of Forte Biosciences, Inc.. The most heavily invested institutionals were:
FRED ALGER MANAGEMENT, LLC: 1.64 M
FEDERATED HERMES, INC.: 1.64 M
JANUS HENDERSON GROUP PLC: 1.4 M
ORBIMED ADVISORS LLC: 1.2 M
TYBOURNE CAPITAL MANAGEMENT (HK) LTD: 786,647
VANGUARD GROUP INC: 566,741
88.08% of Forte Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.59 M shares in the last 24 months. This purchase volume represents approximately $164.09 M in transactions.